Home

Court action looms over DoH anti-flu drug guidance

2000-12-07T00:00:00

A company which distributes an anti-flu drug that is a tenth of the price of Relenza is considering legal action against the Department of Health after accusing it of restraint of trade.

You need to be signed in to read more

HSJ

Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All of HSJ.co.uk and our HSJ mobile app
  • News and insight on all areas of public funded healthcare
  • Expert commentary, insight and analysis from industry leaders
  • 9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

Subscribe

to HSJ

Sign into your account here